Getting the word out, straight from the source.

MED Institute is a proud collaborator of two new CDRH Research Programs. For more details, please read more about the initiative in FDA’s press release below.

CDRH Science Update: Research Programs Webpages in the Office of Science and Engineering Laboratories at CDRH

March 1st, 2016

The Office of Science and Engineering Laboratories (OSEL)/Center for Devices and Radiological Health (CDRH) is pleased to announce the new OSEL Research Programs webpages.

OSEL Research Programs aim to ensure that patients have access to high quality, safe and effective medical devices. They advance regulatory science—the science of developing new tools, standards and approaches to assess the safety, efficacy, quality, and performance of medical devices and radiation-emitting products. Science at OSEL includes laboratory and field research in the areas of physical, life, and engineering sciences as well as epidemiological research in postmarket device safety. Our collaborations with academia, healthcare providers, other government agencies and industry support CDRH efforts to ensure public safety in areas as varied as medical imaging, medical device software, breast implants, and drug eluting stents.

We are increasing our presence on the web to inform patients, clinicians, researchers and medical device colleagues of Research Programs active at CDRH. In addition to the Research Programs webpages, the programs can also be accessed through the OSEL homepage, and are also organized by clinical area and special topics, in order to reach varied audiences. Our goal is to provide the public information about research at CDRH, and to allow colleagues to easily find FDA scientists with shared research interests.

MED Institute Opens Satellite Office

December 8th, 2015

West Lafayette, Ind. — MED Institute is pleased to announce the opening of its satellite office in the incubator facility of the Global Cardiovascular Innovation Center (GCIC) in Cleveland, Ohio. Adjacent to the Cleveland Clinic, the GCIC is in a 50,000 sq. ft. facility that has development lab and office space, and the center provides extensive business support services to new companies in the cardiovascular field.      

The GCIC is a cardiovascular product development consortium supported by a grant from the State of Ohio's Third Frontier Program. Its mission is to be an international leader in developing, incubating, and commercializing cardiovascular technology. Its Product Development Acceleration program provides technology and product development expertise to Ohio companies in order to accelerate their commercialization development and success.    

MED intends to have personnel on-site at GCIC part-time initially, to better meet the needs of these innovative companies. MED currently offers the capabilities of prototyping, developing and testing new products. Having a satellite office within the GCIC facility will allow MED to broaden their relationship with Ohio-based companies.